injection de semaglutide Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes Semaglutide (Ozempic) Side Effects &
Description
Along with competitors Promomed and PSK Pharma, these companies have seen rapid sales growth
A team of researchers from the University of Iowa has unveiled concerns about the use of semaglutide, a widely prescribed GLP-1 receptor agonist for type 2 diabetes and obesity, in patients with neuroendocrine neoplasms (NENs)
Because the payoff also promises to be massive
Updated July 2026
Nervous about your first GLP-1 injection
